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Abstract 
ANTI-BACTERIAL PROPERTIES OF ETHANOLIC MORINGA OLEIFERA LEAF EXTRACT AND 
PROTEOMIC ANALYSIS OF ITS EFFECTS ON ESCHERICHIA COLI 
 
Brandon Edward Smith 
B.S., Appalachian State University  
M.S., Appalachian State University 
 
Chairperson: Chishimba Nathan Mowa, Ph.D. 
 Every year 15 million babies are born prematurely worldwide and a million of these 
infants die.  We know that bacterial infections are associated with and are the primary cause of 
preterm labor.  Unfortunately, current antibiotic-based therapies are either unsafe or are 
becoming less effective due to the development of bacterial resistance to these therapies.  Some 
of the key microbes associated with preterm labor include Gardnerella vaginalis, Lactobacillus 
spp., Atopobium vaginae, Mycoplasma hominis, Ureaplasma urealyticum and Escherichia coli (E. 
coli).  Here, we investigated the effectiveness of different whole leaf Moringa oleifera (M. 
oleifera) extracts on E. coli, comparing the most potent leaf extract to common antibiotics.  We 
sought to determine the genome-wide protein expression patterns taking place in the 
bacterium when incubated with whole leaf M. oleifera extract by using quantitative proteomics.  
From these studies, we demonstrate 1) ethanolic whole leaf M. oleifera extract causes greatest 
inhibition of E.coli and is comparable to inhibition observed by common antibiotics, 2) different 
phases of bacterial growth are prolonged or inhibited by extract treatment, and 3) quantitative 
proteomics revealed vast changes in proteins associated with distinct biological processes such 
as stress response, metabolism and energy maintenance. 
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Introduction 
Purpose of Study: 
Every year 15 million babies are born prematurely worldwide and a million of these 
infants die (Beck et. al., 2009).  We know that bacterial infections are associated with and are 
the primary cause of preterm labor (Agrawal & Hirsch, 2012).  Unfortunately, current 
antibiotic-based therapies are either unsafe or are becoming less effective due to the 
development of bacterial resistance to these therapies.  Some of the key microbes associated 
with preterm labor include Escherichia coli (E. coli), Gardnerella vaginalis, Lactobacillus spp., 
Atopobium vaginae, Mycoplasma hominis, and Ureaplasma urealyticum (Beck et. al., 2009; Klein 
& Gibbs, 2004).  Because of these reasons, as well as the fact that more than 80% of the world’s 
population depends on medicinal plants for their primary health, the purpose of the present 
study is to begin to test the effectiveness of widely accessible natural products that have been 
safely used for thousands of years. Moringa oleifera (M. oleifera) fits this description and its leaf 
extract was tested on inhibiting bacterial growth. Specifically, we used E. coli as a model 
microbe and attempted to delineate the underlying mechanism of M. oleifera’s anti-E. coli 
activities using basic bacteriological techniques, as well as proteomics, which in future studies 
will be verified by Western blot and real time PCR analysis, respectively.  The primary 
hypothesis of the present study was that M. oleifera can be used to inhibit the growth of one of 
the key bacteria associated with preterm labor, E. coli. If successful, insights gained from the 
current in vitro study will be used to develop in vivo-based studies using mice models, with 
hopes of extending the studies to humans in the future. 
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Overview: 
Systemic and local bacterial infections have been linked to and believed to be the major 
cause of premature labor (Beck et al., 2009; Klein & Gibbs, 2004).  Premature labor is a common 
phenomenon and represents a costly health care condition around the world (Blencowe et al., 
2012).  Every minute more than 100 infants die from premature births, while over 1,400 babies 
are born prematurely and many will live with and suffer from life-long side effects (Beck et al., 
2009; Reddy et al., 2012).  For now, the exact mechanisms that lead to premature fetal delivery 
are not completely understood. However, we do know that premature delivery is largely caused 
by microbial infection that subsequently triggers an inflammatory response (El-Bastawissi et 
al., 2000; Romero, Avila, Santhanam, & Sehgal, 1990; Romero et al., 2006). 
 Bacteria, such as Escherichia coli, Gardnerella vaginalis, Lactobacillus spp., Atopobium 
vaginae, Mycoplasma hominis, and Ureaplasma urealyticum, have the ability to colonize the 
placenta during fetal development through many different routes, including the urinary and 
circulatory systems, and, most commonly, via ascension through the vagina to fetal membranes 
and amniotic cavity (Beck et al., 2009; Cram, Zapata, Toy, & Baker, 2002; Klein & Gibbs, 2004; 
Romero et al., 1990).  Upon penetration of the bacteria into the epithelial cells of the cervix and 
vagina, the bacterium binds to toll-like receptors (TLRs) and subsequently trigger the 
recruitment of neutrophils and monocytes, eventually leading to an increase in cytokine 
production (Adib-Conquy, Scott-Algara, Cavaillon, & Souza-Fonseca-Guimaraes, 2014; Klein & 
Gibbs, 2004).  Toll-like receptors are membrane-bound proteins that recognize foreign 
invaders, including bacteria, and are believed to play a crucial role in infection-mediated 
preterm birth (Challis et al., 2009). 
Urinary Tract Infections (UTIs) are very common during pregnancy and E. coli is the key 
contributor of UTIs (Ovalle & Levancini, 2001).  E. coli is also one of the most common 
pathogenic bacteria associated with preterm labor and isolated from pregnant women (Ovalle 
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& Levancini, 2001).  Antibiotics, such as tetracycline and ciprofloxacin, are commonly used to 
treat E. coli-induced UTIs (Blair, Webber, Baylay, Ogholu, & Piddock, 2015). However, the 
problems associated with use of antibiotics are resistance and safety, particularly during 
delicate biological events, such as pregnancy (Blair et al., 2015). Other than posing health risks 
and resistance, use of antibiotics, especially in poor countries or communities, is also more 
costly or may not be available (Blair et al., 2015). Since 80% of the world’s population rely on 
medicinal plants, it is essential to test the efficacy of medicinal plants in treating infection-
induced preterm labor (Fahey, 2005). 
Thus, new therapies that are both safe to the fetus and mother and effective against 
preventing bacterial infections are needed to combat preterm labor.  Historically, plant extracts 
have been used for a long time as medical ointments for treating many illnesses, and continue to 
be used to this day, especially in developing countries, where modern medicine is either too 
costly or perhaps unavailable.  Various conditions treated with plant extracts include infection, 
inflammation and pain (Fahey, 2005; Kasolo, Bimenya, Ojok, Ochieng, & Ogwal-Okeng, 2010).  
M. oleifera has been used safely as a medicinal plant world-wide for thousands of years (Mbikay, 
2012). It has been reported to help reduce a plethora of illnesses, including inflammation, high 
cholesterol, UTI infection and depression, while boosting the immune system and energy 
(Charoensin, 2014; Konda, Madhavi, Ruckmani, & Venkataramana, 2013; Mbikay, 2012). 
M. oleifera has lately received increased attention for its medicinal and nutritional 
properties and several of its bioactive phytochemicals have been identified, including catechol 
tannins, gallic tannins, steroids and triterpenoids, flavonoids, saponins, anthraquinones, 
alkaloids reducing sugars and many more (Fahey, 2005; Kasolo et al., 2010; Muhammad, Pauzi, 
Arulselvan, Abas, & Fakurazi, 2013).  Various M. oleifera leaf extracts have also been shown to 
contain many bioactive compounds that exert anti-proliferative properties against bacteria 
such as E. coli, Staphylococcus aureus, Vibrio cholerae, and Salmonella enteritidis. These bioactive 
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compounds (with anti-proliferative properties) include benzyl isothiocyanate, 4-benzyl 
isothiocyanate, niazimicin, pterygospermin, and 4-benzyl glucosinolate (Bukar, Uba, & Oyeyi, 
2010; Fahey, 2005; Mahbub, Hoq, Ahmed, & Sarker, 2011; Oluduro, 2012), and appear to be 
unique to the Moringa genus, making M. oleifera a potential treatment of choice for infection-
induced preterm labor (Fahey, 2005).  Indeed, bacteria, such as E. coli, S. aureus, Pseudomonas 
aeruginosa, and Proteus mirabilis that are associated with preterm labor, have been shown to be 
hindered by M. oleifera leaf extract’s anti-bacterial properties in non-reproductive tissues 
(Abraham & Okon, 2014; Bukar et al., 2010; Fahey, 2005; Mahbub et al., 2011; Oluduro, 2012; 
Rahman et al., 2009; Tiloke, Phulukdaree, & Chuturgoon, 2013). Based on these studies, it is 
reasonable to speculate that M. oleifera could potentially be used to prevent bacterial infection-
induced preterm labor.  It is also rational to speculate that M. oleifera could potentially be 
regulating bacterial replication by preventing key biological processes from occurring.  
In the present study, we examined the antibacterial properties of M. oleifera against E. 
coli, which is commonly associated with urinary tract infection and causes around 20% of 
premature births (McGuire, 2004). We also screened the expression of key proliferation-
associated proteins using proteomics.  A non-pathogenic strain of E. coli, DH5α (lacking type 1 
fimbriae), will be used as a model organism for the pathogenic E. coli which has fimbriae that 
allow it to adhere to the human uroepithelium.   
 
Objectives: 
Here, we attempted to characterize the anti-E. coli activities of M. Oleifera by: 1) testing 
the effectiveness of five different whole leaf extracts of M. oleifera  to prevent bacterial growth 
in an in vitro model and compared the extracts to the commonly prescribed antibiotics for E. 
coli, primarily Streptomycin and Tetracycline and 2) delineated the likely underlying molecular 
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mechanisms of M. oleifera’s anti-E. coli activities by identifying the expression of the signature 
factors that are involved in key biological processes using proteomics analysis. 
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Materials and Methods 
Microbe Used: 
 
A non-pathogenic strain of E. coli, D51α, generously provided by Dr. Ece Karatan 
(Department of Biology, Appalachian State University, Boone, NC), was used in this project due 
to its ease in growing and safety. In all the experiments conducted in the present study  
disposable sterile petri dishes (VWR, Radnor, Pennsylvania, USA) with LB agar (AMERCO, Ohio, 
USA) were used. The petri dishes were divided into 4 quadrants, streaked and labeled (Figure 
1). Thereafter, the petri dishes were placed in a 37 °C incubator for about 24 hours to allow 
sufficient growth of bacterium. Single bacterial colonies obtained from these experiments were 
then placed in liquid culture to be used in later procedures. 
 
Preparation of Agar Plates: 
To make agar plates, 22 grams of premix LB Agar Powder (Ameresco, Solon, Ohio, USA) 
was weighed and added to a flask containing 250 mL of distilled-water (dH20), and thereafter 
thoroughly mixed and autoclaved (Steris Ameresco, Ohio, USA) at 121°C for 20 minutes, before 
cooling for approximately 20 minutes. About 12.5 mL of the cooled agar solution was then 
added to each of the 20 sterile petri dishes (VWR, Radnor, Pennsylvania, USA) that were placed 
on a sterilized table. The plates were allowed to cool for another 25 minutes and the dishes 
were then placed in a refrigerator set at 4 °C for storage. 
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Preparation of Glycerol Cultures: 
Liquid bacterial cultures were used throughout this experiment in order to limit 
contamination of plate cultures due to repeated exposure to the environment. A single colony of 
bacteria was scrapped from the petri dish  and carefully inoculated into 2 mL of LB (Amresco, 
Solon, Ohio) broth using aseptic techniques. The inoculated broth culture was then placed in a 
37°C incubator for 24 hours and thereafter stored at -80°C.  Bacteria cultures were then 
counted for colony-forming units by doing serial dilutions and plating.  A consistent 
concentration of 1500 CFU/μL was maintained for stock bacteria cultures.  The cultured 
bacteria was then pelleted and re-suspended in 2 mL of 15% glycerol solution for storage. Each 
stock solution was used for three experiments by adding bacteria to LB (Amresco, Solon, Ohio) 
broth and then discarded to limit contamination. 
 
Preparation of Stock M. oleifera Extracts: 
 The whole leaf extracts of Moringa were generously provided by our collaborators, Drs. 
Joshua Idassi and Jahangir Emrani of North Carolina A &T University (NC A & T), Greensboro, 
NC, where the plant was grown, harvested and processed. Briefly, after harvest, the leaves were 
carefully dried, blended into powder and then dissolved in 5 different solvents (ethanol, 
ethanol/water (80/20), methanol, butanol and water) for extraction. The solvents were then 
evaporated through rotary evaporation.  The final extracts were then suspended in sterile 0.1 M 
PBS (Table 1). 
 
Disk Diffusion Assay: 
Aseptic techniques were used throughout the present study in all procedures.  To 
prepare the diffusion assay, 200 μL of stock E. coli/LB (1500 CFU/μL) broth was spread on an 
LB agar petri dish. The dishes were then allowed to dry for 10 minutes.  Sterile discs (3) were 
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then evenly placed throughout the petri dish.  The appropriate amount (amount to be used 
depended on experiment) of M. oleifera extract solution was then pipetted onto each of the 
disks and, the dishes were incubated overnight at 37 °C. After incubation, the diameter of 
inhibition zones were then measured in millimeters (mm) by using a ruler, with the smallest 
unit estimated at ½ mm (Figure 2). 
 
Determination of Minimum Inhibitory Concentration and Minimum Bactericidal Concentrations: 
 In order to determine the minimum inhibitory concentration (MIC), different 
concentrations of M. oleifera plant extract were added to LB agar plates with E. coli, as explained 
earlier under the diffusion assay protocol above.  Plates were then incubated for 24h at 37°C 
and examined for microbial growth.  Plain solvents, lacking the plant extracts (ethanol, 
methanol, butanol, water), as well as 0.1M PBS (final solvent after evaporation of initial 
solvents), were used as controls.  The MIC was defined as the lowest concentration of the 
extract at which an inhibitory zone was first detected. 
In order to determine the minimum bactericidal concentration (MBC), different 
concentrations of M. oleifera plant extract were added to tubes containing 2 mL of LB medium 
plus 20 μL cell culture (1500 CFU/μL). After incubation (37°C for 24h), an aliquot (10 μL) of 
each sample that did not show visible growth were inoculated onto plates containing LB agar. 
Plates were incubated for 24h at 37°C and then examined for microbial growth. Again, plain 
solvents (ethanol, methanol, butanol and water), as well as 0.1M PBS were used as controls. The 
MBC was defined as the lowest concentration of the extract at which no microbial growth was 
detected. 
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Lethal Dose 50% (LD50): 
 LD50 studies were then conducted in order to determine the extract with the most 
potent anti-bacterial effects, as well as compare the potency of the 100% ethanol Moringa 
oleifera extract versus select antibiotics (Tetracycline, ampicillin and streptomycin).  The cell 
concentration of E. coli added to the broth culture was 20 μL (1500 CFU/μL).  All the 
experimental groups were incubated at 37°C and shaken at 200 rpm in an incubator for 24h.  
LD50 was determined as the absorbance ratio of the control group (bacteria with no treatment) 
versus experimental groups at OD600 using a spectrophotometer.  The LD50 was the 
concentration at which the experimental groups’ absorbance was half that of the control 
group’s absorbance. Each experiment was carried out in triplicate. 
 
Antibacterial Kinetic Plots: 
 Following the determination of MIC and MBC, we then examined the antibacterial 
kinetics of M. oleifera against E. coli. The experimental set up, as well as concentrations of M. 
oleifera were as follow: a) Negative control (vehicle only); b) Treatment groups: Dose-
dependent treatments of M. oleifera: i) 0.75 μg/mL, ii) 1.5 μg/mL and iii) 3 μg/mL, respectively; 
c) Positive control groups:  Streptomycin, tetracycline, and ampicillin were used as positive 
(antibiotic) controls using their respective LD50 concentrations.  The cell concentration of E. coli 
added to the broth culture was 10 μL/mL (1500 CFU/μL).  All the experimental groups 
(controls and treatment groups) were then incubated at 37°C and shaken at 200 rpm in an 
incubator with a shaker. At the following time points: 0, 1h, 2h, 4h, 8h, 16h, 24h, 48h and 72h, 
the absorbance in each 2 mL culture was measured in order to depict a growth pattern of the 
incubated E. coli.  The antibacterial kinetic patterns were made by measuring optical density at 
600 nm (OD600) determined using a spectrophotometer.  Each experiment was performed in 
triplicates. 
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Proteomics: 
Following the basic microbial and morphological studies, we then sought to investigate 
the underlying mechanism of Moringa’s effects on E. coli using proteomics.  
Sample preparation and treatments: Briefly, samples were prepared by adding 2 mL of 
LB broth to six tubes (Triplicates studies for both negative control and treated groups).  Twenty 
μL of E. coli was then added at 1500 CFU/μL and placed in an incubator to allow growth for a 
total of 24 h at 37˚C and rotation of 200 rpm.  Control samples (bacteria alone) were left in the 
incubator for the entire 24 h without any additional treatment.  For the treatment group 2.5 
μg/mL of ethanolic M. oleifera whole leaf extract was added to each sample at 16 h of incubation 
and the samples were immediately placed back in the incubator for the remaining 8 hrs.  
Samples were then recovered from the incubator and placed in -80˚C at the end of the 24 h 
incubation. Protein was then extracted from the samples (as described below) and then sent to 
the David Murdock Research Institute at Kannapolis, NC, for proteomics analysis.  The 
remaining portion of the proteomic methods were performed at the David Murdock Research 
Institute by David Kirchner. 
Protein extraction and sample concentration: Total protein for proteomics was 
extracted from 6 samples, 3 control and 3 treatment, of E. coli cells using the protein inhibitor 
cocktail and cell lysis buffer from Sigma Aldrich (St Louis) and the supernatant was 
immediately stored at -80°C. The core facility Laboratory of the David Murdock Research 
Institute (Kannapolis, NC) performed the proteomics analysis and selected proteins from the 
proteomics data were then analyzed. 
Protein samples were concentrated using 3 KDa Molecular Weight Cut-Off (MWCO) spin 
filters (Amicon) following the manufacturers protocol for concentrating protein samples. The 
entire volume of each sample (400-500 μL each) was loaded into clean, separate spin filter 
devices and centrifuged at 14,000g for approximately 30 minutes until volumes were reduced 
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to approximately 20 μL each. The filters were then inverted and placed into clean collection 
tubes and centrifuged for 2 minutes at 1,000 g to collect the protein concentrate. After the 
samples were concentrated, they were dried down in a vacuufuge for 40 minutes at 30°C. The 
protein samples were reconstituted in 100 μL of LC/MS grade H2O and briefly sonicated, 
vortexed and then centrifuged. The samples were then transferred into clean, labeled micro-
tubes and BCA assays were performed. 
Micro BCA assay: The protein concentration of the 6 samples was determined using a 
microBCA assay (Thermo) following the manufacturers protocol. 
Reduction, Alkylation and Trypsin Digestion: The results from the first trial microBCA 
assay were used to measure out 10 μg of each protein sample for enzyme digestion and MS 
analysis. Then LC/MS grade water was added to bring each sample to a concentration of 2μg/μl.  
Two (2) μL of 10 mM Dithiothreitol (DTT) was added to each sample tube and the tubes were 
incubated at 80°C for 30 min. Then 2μL of 200 mM Iodoacetamide (IAA) was added and tubes 
were incubated at room temperature in the dark for 20 min. One (1) μL of a 200 ng/μL Trypsin 
solution in 50 mM Ammonium Bicarbonate (AmBiC) was added and the tubes were incubated 
for 5 h at 37°C then overnight at 4°C. The reactions were quenched by adding 1 μL of 10% acetic 
acid to the reaction tubes. The tubes were then briefly centrifuged to place any condensate from 
incubation at the bottom of the tubes. The samples were vacuufuged for 30 min at 30°C. Each 
sample was then reconstituted in 25 μL liquid chromatography loading buffer (2% Acetonitrile, 
0.1% formic acid), and briefly sonicated to solubilize the peptides, and the whole 25 μL of 
sample was transferred into clean, labeled LC/MS vials for data collection and analysis. The 
generation of a pooled quality control (pQC) sample was accomplished by transferring 3.0 μL of 
each peptide sample in a clean, labeled LC/MS vial. 
 Sample preparation for the second trial was similar to the first trial reaction setup, but 
using the second Trial microBCA results that were obtained after sample concentration using 3 
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KDa MWCO spin filter and resuspension. Additionally, the reactions in this trial were 
normalized to equal 20 μg of protein per sample, with the amount of water needed calculated 
by subtracting the needed protein sample amount from 10.0 μL.  As before, 3μL of 10 mM DTT 
was added to each sample and the tubes were incubated at 80°C for 30 min. Three (3) μL of 200 
mM IAA was added and tubes were incubated at room temperature in the dark for 20 min. Then 
2 μL of 200 ng/μL Trypsin solution in 50 mM AmBiC was added and the tubes were incubated 
for 5 hours at 37°C then overnight at 4°C. The reactions were quenched by adding 1 μL of 10% 
acetic acid to the reaction tubes. The tubes were then briefly centrifuged to place any 
condensate from incubation at the bottom of the tubes. The samples were vacuufuged for 30 
min at 30° C and dried down. Each sample was then reconstituted in 20 μL liquid 
chromatography loading buffer (2% ACN, .1% FA) and briefly sonicated to solubilize the 
peptides. All 20 μL of sample was transferred into clean, labeled LC/MS vials for data collection 
and analysis. The generation of a pooled QC (pQC) sample was accomplished by transferring 3.0 
μL of each peptide sample in a clean, labeled LC/MS vial. 
Capillary Chromatography and LC-MS/MS Analysis: Three μL of each sample was 
injected for analysis on an LTQ-Orbitrap XL MS. First, on-line reversed phase C18 sample 
trapping, cleanup and focusing was employed for the first 10 min of each analysis. Then, a 33 
min elution gradient was used for analytical C18 separation of the tryptic peptides. Fifty 
femtomoles of standard Yeast Enolase tryptic digest was injected as a QC sample to monitor 
instrument stability at the beginning and the end of data collection. 
The MS method employed was Full scan profile MS at 60,000 resolution 350 - 1800 m/z 
followed by top 3 in abundance selection for centroided tandem Collision Induced Dissociation 
(CID) MS and a decision tree based Electron Transfer Dissociation (ETD) activation 
fragmentation option. 
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Database Searching and PEAKS Analysis: Data analysis was done by importing the RAW 
data files into PEAKS (BSI Software).  Parameters for the PEAKS analysis can be found in Table 
2 (Table 2). 
 
Statistical Analysis: 
Data were analyzed using Student's t test and ANOVA (single factor).  P-values ≤ 0.05 
were considered to be statistically significant. 
Proteomics: The aligned mass features were annotated with the database search results 
using the results from the system Peptide Tellers and a predicted error rate of 1%.  MS data 
were summarized to the feature level, normalized, and an error-weighted ANOVA test was 
performed to compare the expression results between sample groups.  Candidate differentially 
expressed markers were determined based on a p<0.01.  Biological processes each protein was 
involved in were summarized by protein based on the results of the database search and 
previous literature on proteomics. 
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Results 
Only Ethanol and Hydro-ethanol Leaf Extracts of M. oleifera Inhibit Bacterial Growth Based on 
Diffusion Assay: 
All five M. oleifera extracts were tested at the same concentration to determine the 
extract with the most potent antibacterial activities based on the diameter of the inhibition 
zones (Figure 3).  According to data from the diffusion assay experiments, only two M. oleifera 
extracts out of the 5 different solvents exhibited antibacterial properties by preventing E. coli 
growth based on the diameter of the inhibition zones, with the most significant inhibition 
(greatest diameter) displayed by both ethanol-based solvents (Figure 3). Of the two ethanol-
based extracts, the pure ethanol extract exhibited a greater inhibition than the hydro-ethanol 
extract (80% ethanol) by approximately 2-fold magnitude in inhibition. The rest of the extracts, 
including butanol, methanol and water extracts displayed an inhibitory zone with a diameter of 
6 mm (Figure 3), which was indicative of zero inhibition of E. coli growth (bacterial growth all 
the way up to the disc (Figure 3)). 
 
Ethanol-based Leaf M. oleifera Extracts Inhibit E. coli Growth in a Dose-dependent Manner:  
 Since the ethanol-based M. oleifera extract showed the highest antibacterial effects, we 
next conducted experiments aimed at determining the minimal concentration of M. oleifera 
required to inhibit the growth of E. coli and whether it was dose-dependent (Figure 4).  The 
minimal concentration of the M. oleifera whole leaf extract for ethanol-based solvents (pure 
ethanolic and hydro-ethanolic) ranged between 1 to 20 μg, with the largest zone of inhibition 
on E. coli growth exhibited by the pure ethanol in a dose-dependent manner (Figure 4). 
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The inhibitory effect of the pure ethanol extract was so potent that we were unable to 
determine the minimum inhibitory concentration of the solvent even at 1 μg, which prompted 
us to dilute the extracts even further (Table 3).  The minimum inhibitory and minimum 
bactericidal concentrations for the pure ethanol extract were found to be 0.75 and 3 μg/mL, 
respectively, whereas, those of the hydo-ethanolic extract were 1.5 and 7-8 μg/mL, respectively 
(Table 3).  The inhibitory and bactericidal concentrations for the other solvents could not be 
determined even at greater than 20 μg/mL of the extracts (Table 3). 
 
M. oleifera Extracts Inhibit E. coli Growth at Comparable Masses to Commonly Prescribed 
Antibiotics: 
The extent to which the 5 different M. oleifera leaf extracts inhibited bacterial growth 
were then compared to antibiotics commonly prescribed for E. coli infection (Ciprofloxacin and 
tetracycline) at comparable masses (5 μg) using diffusion assays.  Clindamycin (5 μg) was used 
as a negative control and showed no inhibition on E. coli growth.  Both ethanol-based extracts 
exerted inhibition zones at 5 μg, with the ethanol extract having stronger inhibitory effects 
when compared to hydro-ethanolic extract (Figure 5).  Also, both tetracycline and ciprofloxacin 
antibiotics exerted inhibition at 5 μg, with ciprofloxacin exhibiting the largest inhibition zone at 
35 mm (Figure 5).  The ethanol extract had the second largest inhibition zone at approximately 
65% that of ciprofloxacin (Figure 5).  It was interesting to note that the hydro-ethanolic extract 
had a larger zone of inhibition compared to tetracycline, i.e., 18 mm versus 14 mm, respectively 
(Figure 5). 
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Ciprofloxacin is Four Times More Potent in Inhibiting Bacterial Growth than M. oleifera Ethanol 
Extract:   
Next, we sought to determine the concentration of the ethanolic extract required to 
produce a comparable inhibition zone to ciprofloxacin at 5μg.  Since only the extract from pure 
ethanol exhibited the largest inhibition zone in preceding experiments, it was the only extract 
tested in subsequent experiments.  Data revealed that at a mass of 25μg the pure ethanolic 
extract exerted an inhibition zone that was comparable to ciprofloxacin at 5μg, implying that 
the antibiotic was 4-fold more potent than the extract (Table 4). 
 However, the inhibition zones of the pure ethanolic extract at 25μg on average tended 
to be slightly larger, by approximately 4-5 mm, than those produced by ciprofloxacin at 5µg 
(Figure 6).  This shows that the inhibition zone of the ethanol extract at 25μg was 
approximately 120% that of ciprofloxacin (Table 4). 
 
M. oleifera Dose-dependently Disrupts the Growth Kinetics of E. coli:  
Next, we carried out experiments using varying concentrations (0.75 μg/mL, 1.5 μg/mL 
and 3 μg/mL) of Moringa ethanolic extracts over a period of 72 hours (h), with the goal of 
examining the effects of M. oleifera on the growth kinetics of E. coli.  The three different 
concentrations of the ethanolic extract were compared to the positive (only bacteria, no 
extract) and negative (only extract, no bacteria) control groups (Figure 7).  The ethanolic 
extracts were found to change the growth kinetics of E. coli when compared to both controls 
(Figure 7).  Specifically, at 3 μg/mL of ethanolic extract, a concentration considered as the MBC, 
there was zero growth noted throughout the different time points, up to a total of 72h 
treatment period (Figure 7).  At 1.5 μg/mL of ethanolic extract, a delay in growth lasting 14h 
was noted, before the onset of exponential growth phase, maximum growth was only 2/3 
compared to the positive control and total lysis was observed after 72 h (Figure 7).  At 0.75 
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μg/mL of ethanolic extract a similar delay to the 3μg extract was observed. However, the overall 
growth was very similar to that of the positive control (Figure 7). 
 
Comparison of Lethal Dose 50% of Ethanolic M. oleifera Extract Versus Common Antibiotics: 
 We then conducted LD50 experiments with varying concentrations of the ethanol M. 
oleifera extract and compared them to those of select antibiotics against E. coli at 24 hours 
(Table 5).  The LD50 for pure ethanol M. oleifera extract against E. coli was found to be between 
2-2.5 μg/mL (Table 4). Streptomycin was found to have the lowest LD50 at 4-5 μg/mL (Table 5), 
and those of tetracycline and ampicillin were 7.5 and 12.5 μg/mL, respectively (Table 5). 
 
 
Effects of Select Antibiotics on the Growth Kinetic Patterns of E. coli: 
 Next, we conducted experiments that examined the effects of select antibiotics 
(Ampicillin, streptomycin and tetracycline) on the growth kinetics patterns of E. coli at varying 
concentrations up to 72 hours and at three different concentrations for each antibiotic (1/2 
LD50, LD50, and 2x LD50). These antibiotics were compared to positive (only bacteria, no 
antibiotic) and negative controls (only antibiotic, no bacteria), as described earlier for M. 
oleifera above. 
 Ampicillin was only found to change the growth kinetics of E. coli at two time points 
when compared to controls (Figure 8).  Specifically, at the concentration of ½ LD50, LD50, and 2x 
LD50, ampicillin was able to reduce growth at the 8h time point when compared to the positive 
control (Figure 8) and, at 2x LD50, ampicillin showed inhibition of E. coli growth at the 16h time 
point when compared to the positive control (Figure 8).  Ampicillin was not able to show any 
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other significant changes in the growth of E. coli at any other time points, compared to the 
positive control (Figure 8). 
Streptomycin was found to change the growth kinetics of E. coli when compared to 
controls (Figure 9).  Specifically, at the concentrations of ½ LD50, LD50 and 2x the LD50, 
streptomycin was able to reduce growth observed at the 8h, 16h, and 24h time points when 
compared to the positive control (Figure 9). Whereas, at 2x the LD50 streptomycin 
concentration also showed reduced levels of E. coli growth at 48h and 72h time points, when 
compared to the positive control (Figure 9). 
Tetracycline was able to change the growth kinetics of E. coli when compared to the 
control groups (Figure 10).  Specifically, at the concentration of ½ LD50, LD50, and 2x LD50, 
tetracycline was able to extend the lag phase, and reduce overall growth when compared to the 
positive control (Figure 10).  At the LD50 and 2x the LD50 tetracycline concentration a difference 
in E. coli growth was observed at all time-points when compared to the positive control (Figure 
10). The greatest difference in E. coli growth between tetracycline and positive control was 
noted at 2x LD50 (Figure 10).  Also, a notable difference in E. coli growth was observed after 16h 
at ½ LD50 concentration of tetracycline, when compared to the positive control (Figure 10). 
 
 
Proteomics Analysis Reveals that M. oleifera Alters Multiple Biological Processes and Protein 
Expression: 
 Proteomics analysis was utilized to see the change in protein expression observed when 
E. coli was treated with ethanolic M. oleifera whole leaf extract, with the goal of delineating 
underlying mechanisms of action.  Proteomics analysis revealed that 64 identifiable proteins in 
E. coli were modulated by M. oleifera compared to the control (no treatment) group (Figure 11).  
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These 64 proteins were found to have many different biological functions and only a small 
subset, 13 proteins, were found to be significantly changed (Table 6).   
The modulated proteins identified during the analysis of the proteomics data were 
placed into biological processes that were affected by their primary function.  The biological 
processes included: stress response, metabolism, translation, ribosome synthesis, membrane 
synthesis, ATP synthesis, ion binding, protein synthesis, DNA binding, and periplasmic-binding 
(Other) (Figure 12). 
 Based upon a protein’s primary function within a cell, two biological processes, 
metabolism and stress response were found to be affected the most by the ethanolic M. oleifera 
whole leaf extract treatment (Figure 12).  Proteomics data showed17 proteins involved in 
metabolism that changed, accounting for 26% of the overall change in variable protein 
expression observed (Figure 12).  There were 20 proteins involved in stress response that 
changed, accounting for 31% of the overall change in variable protein expression observed 
(Figure 12).  Metabolism and stress response biological processes accounted for 57% of the 
overall change in variable protein expression.  The remaining 8 biological processes had ≤ 5 
(8%) proteins changed in each process, accounting for 43% of the overall change in variable 
protein expression (Figure 12). 
 
 
Quantitative Proteomics Expression Analysis of Selected Significantly Changed Stress Response 
Proteins: 
 Significantly changed stress response proteins were selected for quantitative expression 
analysis including isocitrate dehydrogenase [NADP] (IDH), DNA-binding protein HU-alpha, 
ornithine carbamoyltransferase chain F, and alcohol dehydrogenase propanol-preferring 
(ADHP) (Figure 13).  Selected stress response proteins were found to have significantly 
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increased expression for 3 of 4 proteins when E. coli cells were treated with ethanolic M. 
oleifera whole leaf extract (Figure 13).  DNA-binding protein HU-alpha was the only selected 
stress response protein that had a significant decrease in expression, approximately 35%, when 
E. coli cells were treated with ethanolic M. oleifera whole leaf extract (Figure 13).  IDH was 
found to have an increase of approximately 2-fold between control (no treatment) and 
ethanolic Moringa treated E. coli cells (Figure 13).  Ornithine carbamoyltransferase chain F was 
found to have an increase of approximately 6.5-fold between control (no treatment) and 
ethanolic Moringa treated E. coli cells (Figure 13).  ADHP was found to have an increase of 
approximately 3-fold between control (no treatment) and ethanolic Moringa treated E. coli cells 
(Figure 13). 
 
 
Quantitative Proteomics Expression Analysis of Selected Significantly Changed Proteins Involved in 
Metabolism: 
 Significantly changed proteins involved in metabolism were selected for quantitative 
expression analysis including uncharacterized oxidoreductase YajO, and malate dehydrogenase 
(MDH) (Figure 14).  Selected proteins involved in metabolism were found to have significantly 
increased expression for both selected proteins when E. coli cells were treated with ethanolic M. 
oleifera whole leaf extract (Figure 14).  Uncharacterized oxidoreductase YajO was found to have 
an increase of approximately 2-fold between control (no treatment) and ethanolic Moringa 
treated E. coli cells (Figure 14).  MDH was found to have an increase of approximately 2.25-fold 
between control (no treatment) and ethanolic Moringa treated E. coli cells (Figure 14). 
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Quantitative Proteomics Expression Analysis of Selected Significantly Changed Proteins Involved in 
ATP Synthesis: 
 Significantly changed proteins involved in ATP synthesis were selected for quantitative 
expression analysis including ATP synthase subunit c, Succinyl-CoA ligase subunit beta (SUCC), 
and Succinyl-CoA ligase subunit alpha (SUCD) (Figure 15).  Selected proteins involved in ATP 
synthesis were found to have significantly increased expression for all three selected proteins 
when E. coli cells were treated with ethanolic M. oleifera whole leaf extract (Figure 15).  ATP 
synthase subunit c was found to have an increase in expression of approximately 2-fold 
between control (no treatment) and ethanolic Moringa treated E. coli cells (Figure 15).  SUCC 
was found to have an increase in expression of approximately 2-fold between control (no 
treatment) and ethanolic Moringa treated E. coli cells (Figure 15).  SUCD was found to have an 
increase in expression of approximately 2.25-fold between control (no treatment) and ethanolic 
Moringa treated E. coli cells (Figure 15). 
 
 
Quantitative Proteomics Expression Analysis of Selected Significantly Changed Proteins Involved in 
Translation, Ribosome Synthesis, Membrane Synthesis, and Periplasmic-binding: 
 Significantly changed proteins involved in translation, ribosome synthesis, membrane 
synthesis, and periplasmic-binding were selected for quantitative expression analysis including 
50S ribosomal L5 for translation, ribosomal large subunit pseudouridine synthase B as the 
protein involved in ribosome synthesis, Enoyl-[acyl-carrier-protein] reductase [NADH] FabI as 
a protein involved in membrane synthesis, and glutamate/aspartate periplasmic-binding 
protein as a periplasmic-binding functioning protein (Figure 16).  Selected proteins involved in 
ribosome synthesis, membrane synthesis, and periplasmic-binding were found to have 
significantly increased expression for all three selected proteins when E. coli cells were treated 
with ethanolic M. oleifera whole leaf extract (Figure 16).  The selected protein involved in 
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translation was found to have a significant decrease in expression for the selected protein when 
E. coli cells were treated with ethanolic M. oleifera whole leaf extract (Figure 16).  The protein 
involved in ribosome synthesis, ribosomal large subunit pseudouridine synthase B, was found 
to have an increase in expression of approximately 2-fold between control (no treatment) and 
ethanolic Moringa treated E. coli cells (Figure 16).  The protein involved in membrane synthesis, 
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI, was found to have an increase in 
expression of approximately 2-fold between control (no treatment) and ethanolic Moringa 
treated E. coli cells (Figure 16).  The periplasmic-binding functioning protein, 
glutamate/aspartate periplasmic-binding protein, was found to have an increase in expression 
of approximately 3-fold between control (no treatment) and ethanolic Moringa treated E. coli 
cells (Figure 16).  The protein involved in translation, 50S ribosomal protein L5, was found to 
have a decrease in expression of approximately 40% between control (no treatment) and 
ethanolic Moringa treated E. coli cells (Figure 16). 
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Discussion 
 The present study uses in vitro techniques to examine the biological effects of M. oleifera 
on E. coli. The overall objective of the present study was to characterize the anti-bacterial 
properties as well as underlying mechanism of action of M. oleifera in vitro, with the long-term 
goal of testing the effectiveness of M. oleifera in preventing preterm labor. Specifically, we 
screened different whole leaf extracts of M. oleifera for anti-bacterial activities and bacterial 
growth compared to commonly used antibiotics using various in vitro assays. Only the ethanol-
based extracts (pure ethanolic and hydro-ethanolic) was found to exert significant anti-
bacterial activity against E. coli.  These data confirms earlier findings on the anti-bacterial 
properties of M. oleifera and highlights its potential use as a natural anti-bacterial agent for the 
management and prevention of infection-induced preterm labor and other disorders.  
The medicinal activities of M. oleifera have been widely reported, including anti-
bacterial properties (Anwar, Latif, Ashraf, & Gilani, 2007; Colicchio et al., 2015; Dewangan et al., 
2010; Mbikay, 2012; Pal, Mukherjee, & Saha, 1995; Sreelatha, Jeyachitra, & Padma, 2011), and, 
notably, its inhibitory effects on E. coli growth using extracts of different solvents and parts of 
the plant (Auwal et al., 2013; Ekundina, Ebeye, Oladele, & Osham, 2015; Thilza et al., 2010).  In 
the present study, of the five different solvents (water, methanol, butanol, ethanol, and a hydro-
ethanolic, 80/20) used to extract phytochemicals from Moringa leaves, only the ethanol-based 
extracts (ethanolic and hydro-ethanolic) were able to inhibit E. coli growth. These current 
observations are consistent with earlier microbial studies that used ethanol-based extracts, 
including earlier E. coli studies (Adline & Devi, 2014; Bukar et al., 2010; Lar, Ojile, Dashe, & 
Oluoma, 2011). Previous HPLC studies have examined the various phytochemical compounds 
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from seeds and leaves using various solvent extracts, including ethanol and methanol (Bennett 
et al., 2003; Fahey, 2005; Siddhuraju & Becker, 2003).  Specifically, phytochemical compounds 
isolated using ethanol and methanol solvents include pterygospermin, quercetin-3-O-glucoside 
and quercetin-3-O-(6''- malonylglucoside), kaempferol-3-Oglucoside and kaempferol-3-O-(6''-
malonyl-glucoside), 3-caffeoylquinic acid, 5-caffeoylquinic acid, 4- (4'-O-acetyl-a-L-rhamno 
pyranosyloxy) benzyl isothiocyanate, 4-(a-L-rhamnopyranosyloxy) benzyl isothio cyanate, 
niazimicin, benzyl isothiocyanate, and 4-(a-L-rhamnopyranosyloxy) benzyl glucosinolate. Most 
of these bioactive compounds appear to play a role in both anti-bacterial and anti-inflammatory 
properties, making M. oleifera an ideal treatment for both infection- and or inflammatory-
induced preterm labor (Bennett et al., 2003; El Sohaimy, Hamad, Mohamed, Amar, & Al-Hindi, 
2015; Fahey, 2005; Siddhuraju & Becker, 2003). It appears that the phytochemical activity of 
the whole ethanolic leaf extract of M. oleifera is better suited for inhibiting bacteria in contrast 
to the methanolic leaf extract, whose phytochemical properties appear to have a higher potency 
for inhibiting inflammation and or cancer (Rao, Devi, & Kamath, 2001; Stohs & Hartman, 2015; 
Verma, Vijayakumar, Mathela, & Rao, 2009).  However, the full list of bioactive compounds in 
the ethanol-based leaf extracts for Moringa is incomplete and ongoing studies in our labs are 
currently characterizing a comprehensive list of the compounds, their chemical structures and 
biological activities. 
 The present data generated from experiments that compared the potency of the 
ethanolic extract of M. oleifera whole leaf to inhibit E. coli growth versus commonly prescribed 
antibiotics were insightful and promising, particularly in view of the ever growing resistance to 
a broad range of antibiotics.  We found that the ethanolic extract of M. oleifera whole leaf extract 
significantly inhibited E. coli growth more than selected antibiotics, specifically ampicillin and 
clindamycin at comparable concentrations.  Whereas the ethanolic extract of M. oleifera whole 
leaf significantly inhibited E. coli growth comparable to the antibiotics, specifically tetracycline 
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and streptomycin at comparable concentrations. However, ciprofloxacin was found to be 4-fold 
more potent than M. oleifera and had a greater potency in inhibiting E. coli growth. These 
current findings are consistent with an earlier report (Kumar, Pandey, Mohan, & Singh, 2012), 
although some other previous studies have shown that commonly prescribed antibiotics, such 
as tetracycline and ciprofloxacin, inhibit E. coli at lower concentrations when compared to 
whole leaf extracts from M. oleifera (Kumar et al., 2012; Thilza et al., 2010), thus contradicting 
the present data. The cause of discrepancy between the present data and these earlier reports 
are not yet clear but could be because of the difference in the solvent and parts of the plant used 
for extraction, i.e., the earlier studies used a combination of water and leaf stalk, and not ethanol 
and whole leaf used here (Thilza et al., 2010). There is need for a more comprehensive anti-
bacterial study that will compare the different activities of various plant parts and solvent 
extracts in a broad range of bacterial species (Kumar et al., 2012). 
Since both Moringa and the select antibiotics used in the present study exhibited similar 
effects on E. coli, including growth inhibition and kinetic changes, it is likely that there perhaps 
some common pathways that likely mediate the effects of the plant and pharmaceuticals, most 
of which have been extensively studied for ciprofloxacin, tetracycline, streptomycin, ampicillin 
and clindamycin (Hermann, 2007; Kohanski, Dwyer, & Collins, 2010; Rafailidis, Ioannidou, & 
Falagas, 2007; Sharma, Jain, Pahwa, & Yar, 2010).  For instance, ciprofloxacin targets DNA 
gyrase, leading to the disrupting of replication and transcription and subsequently in DNA 
fragmentation and cellular death (Sharma et al., 2010). On the other hand, tetracycline kills the 
bacteria by binding to the bacterial 30S ribosomal subunit near the A site, which consequently 
inhibits protein synthesis through the prevention tRNA docking (Zakeri & Wright, 2008). 
Streptomycin interferes with translation by binding to a specific site found on 16S subunit on 
the ribosome with three adenine residues, which is responsible for decoding mRNA (Hermann, 
2007).  This interference, coupled with translation leads to the accumulation of non-functional, 
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incorrectly folded, and in-effective as well as in-efficient proteins that lead to bacterial cell 
death (Hermann, 2007).  Ampicillin, like other penicillin-like antibiotics, is able to act in a 
bactericidal manner by inhibiting and preventing the production of the major cell wall 
component peptidoglycan; the bacterial cell ultimately undergoes cell lysis due to the inhibition 
of cell wall synthesis (Rafailidis et al., 2007).  Clindamycin, the last common antibiotic used to 
compare to M. oleifera, binds to the 23s portion of the 50S subunit of bacterial ribosomes and 
cause premature dissociation of the peptidyl-tRNA from the ribosome, which leads to the 
inhibition of protein synthesis (Kohanski et al., 2010).   
Overall, it appears that all of these key antibiotics against E. coli commonly target key 
cellular processes, such as replication, transcription, protein synthesis, and cell wall synthesis. 
For now, it appears that the ethanolic M. oleifera whole leaf extract inhibits E. coli in a similar 
manner as the key antibiotics, according to analysis of proteomics data, except M. oleifera 
appears to disrupt multiple biological processes including stress response, metabolism, 
ribosome synthesis, membrane synthesis, and ATP synthesis.  It is also interesting to note that 
kinetic patterns show that M. oleifera inhibit E. coli during the different phases of growth at 
different concentrations of the whole leaf extract, a trend that is very similar to that of common 
antibiotics, such as streptomycin, tetracycline and ampicillin. Surprisingly, most of the common 
antibiotics were less effective at inhibiting E. coli growth at comparable concentrations to 
Moringa.  Indeed, in the present study, the ethanolic extract of M. oleifera was able to elicit more 
pronounced changes to the different growth phases of E. coli when compared to tetracycline, 
streptomycin and ampicillin.  The phases most affected by the ethanolic extract of M. oleifera 
whole leaf extract in the present study were the lag, exponential and death phases, within the 
normal kinetic growth pattern of E. coli.  The ethanolic extract of M. oleifera was also able to 
prolong the lag phase, and at 1.5 μg/mL , increased the effects of the death phase, leading to 
complete lysis of E. coli. 
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The exact mechanism through which the ethanolic- and hydroethanolic-extracted 
bioactive compounds exert anti-E. coli properties also remain unclear. Preliminary proteomics 
data shows that ethanolic M. oleifera whole leaf extract alters expression of more than 64 
proteins involved in various biological processes of E. coli, with 13 of the proteins being 
significantly changed. These biological processes are varied and include the stress response, 
metabolic processes, translation, ribosomal synthesis, membrane synthesis, ATP synthesis, and 
other biological processes.  
Stress response proteins identified included isocitrate dehydrogenase [NADP] (IDH), 
DNA-binding protein HU-alpha, ornithine carbamoyltransferase chain F, and alcohol 
dehydrogenase propanol-preferring (ADHP) (Figure 13).  IDH functions enzymatically in the 
Kreb’s cycle by performing oxidative decarboxylation of isocitrate and is regulated by 
phosphorylation and de-phosphorylation (LaPorte, 1993). Regulation of this enzyme only 
occurs when ATP levels are sufficient and this is done by isocitrate dehydrogenase 
kinase/phosphatase (Taylor, Hu, Hart, & McAlister-Henn, 2008).  The increased expression of 
this protein in treated ethanolic M. oleifera whole leaf extract E. coli cells can be indicative of 
oxidative stress, improper protein function, and improper Kreb’s cycle regulation (Krisko, 
Copic, Gabaldon, Lehner, & Supek, 2014).  Another protein identified by proteomics data was 
DNA-binding protein HU-alpha which is a protein involved in protecting the DNA during 
stressful environments (Prieto et al., 2011). However, DNA-binding protein HU-alpha is down-
regulated during ethanolic M. oleifera treatment in E. coli which could indicate fragmentation 
has already occurred, improper packaging of the DNA, or the cells inability to transcribe the 
DNA-protecting protein when compared to control (Khil & Camerini-Otero, 2002). Ornithine 
carbamoyltransferase chain F was another protein involved in stress response with the greatest 
enhancement of 6.5-fold by ethanolic M. oleifera treatment of E. coli according to the proteomics 
data (Figure 13).  This protein has been found to be up-regulated during treatments where 
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DNA-damage is occurring and is involved in overall amino-acid biosynthesis in E. coli and other 
pathogenic organisms such as Staphylococcus aureus (Alves et al., 2014; Khil & Camerini-Otero, 
2002). Alcohol dehydrogenase propanol-preferring (ADHP) was the last selected stress 
response protein to be enhanced by ethanolic M. oleifera extract treatment according to the 
proteomics data (Figure 13).   ADHP functions in breaking down propanol but is enhanced 
during the presence of DNA damaging stimulus, as well as acetaldehyde catabolic processes 
(Khil & Camerini-Otero, 2002). All of these proteins in E. coli treated with ethanolic M. oleifera 
whole leaf extract depict a stress response towards DNA damage, metabolic stress, and cell 
death. 
Proteins involved in metabolism identified during proteomics analysis included 
oxidoreductase YajO, and malate dehydrogenase (MDH) (Figure 14).  Oxidoreductase YajO was 
enhanced by 2-fold by ethanolic M. oleifera treatment in E. coli and functions in thiamine 
metabolism through oxidation-reduction processes (Gagliardi et al., 2016).  MDH was another 
protein involved in metabolism and was enhanced by 2.25-fold by ethanolic M. oleifera 
treatment in E. coli and functions in oxidation-reduction reactions of malate to oxaloacetate 
during fermentation and gluconeogenesis (Sutherland & McAlister-Henn, 1985; Takahashi-
Iniguez, Aburto-Rodriguez, Vilchis-Gonzalez, & Flores, 2016).  The enhancement of these two 
proteins by ethanolic M. oleifera extract in E. coli could potentially mean the bacterium is having 
trouble efficiently metabolizing and is being restricted to fermentation and producing its own 
glucose while scavenging for other carbon sources (Gagliardi et al., 2016; Takahashi-Iniguez et 
al., 2016).  All of these proteins in E. coli treated with ethanolic M. oleifera whole leaf extract 
depict metabolic restriction with a stress response from oxidative metabolism to anaerobic 
metabolism. 
Specific ATP-synthesizing proteins identified during proteomics analysis included ATP 
synthase subunit c, Succinyl-CoA ligase subunit beta (SUCC), and Succinyl-CoA ligase subunit 
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alpha (SUCD) (see Figure 15).  All of these proteins are involved in ATP synthesis and are 
enhanced 2-2.25-fold in E. coli cells treated with ethanolic M. oleifera whole leaf extract (see 
figure 15).  ATP synthase subunit c was enhanced 2-fold according to the proteomics data and is 
involved in ATP synthesis by utilizing proton transport across the membrane, and used to re-
establish the proton gradient across the membrane through ATP hydrolysis (Capaldi, 
Schulenberg, Murray, & Aggeler, 2000; Deckers-Hebestreit, Greie, Stalz, & Altendorf, 2000).  
SUCC and SUCD were also enhanced, 2-fold and 2.25-fold respectively, according to the 
proteomics data and are involved in energy synthesis during aerobic and anaerobic growth 
(Reed, Vo, Schilling, & Palsson, 2003).  SUCC, and SUCD are likely enhanced during ethanolic M. 
oleifera whole leaf extract in E. coli because of the potential fermentation/anaerobic reactions 
needed for survival and these proteins have the capability of producing energy in substrate 
limiting environments by providing succinyl-coA for anaerobic growth when oxidative growth 
is hindered (Capaldi et al., 2000; Goo, An, Kang, & Hwang, 2015; Shimizu, 2013).  All of these 
proteins in E. coli treated with ethanolic M. oleifera whole leaf extract depict membrane 
potential issues, and energy inefficiency due to a potential substrate limiting environment with 
an energy adaptation from aerobic growth to anaerobic growth. 
A variety of proteins identified during proteomics analysis were involved in biological 
processes such as translation (50S ribosomal protein L5), ribosome synthesis (Ribosomal large 
subunit pseudo uridine synthase B), membrane synthesis (Enoyl-[acyl-carrier-protein] 
reductase [NADH] FabI), and periplasmic-binding (glutamate/aspartate periplasmic-binding 
protein) (see Figure 16).  50S ribosomal protein L5 was down-regulated in E. coli treated with 
ethanolic M. oleifera whole leaf extract and functions in assisting 5S RNA attachment to large 
ribosomal subunit (Chen & Williamson, 2013; Spierer & Zimmermann, 1978).  We speculate 
that translation will be inefficient due to the down-regulation of 50S ribosomal protein L5 and 
the lack of RNA attachment to the large ribosomal subunit which can lead to accumulation of 
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faulty large ribosomal subunits in E. coli treated with ethanolic M. oleifera whole leaf extract 
(Chen & Williamson, 2013; Korepanov et al., 2012).  Ribosomal large subunit pseudouridine 
synthase B was enhanced by 2-fold according to the proteomics data and is involved in 
pseudouridine synthase (Conrad, Sun, Englund, & Ofengand, 1998; Del Campo, Kaya, & 
Ofengand, 2001).  Pseudouridine is a key component in ribosomes and is needed for normal 
growth and ribosome function (Charette & Gray, 2000; Del Campo et al., 2001).  Pseudoruridine 
is seen as a post-transcriptional modification and has been postulated to be a piece of an 
adaptive mechanism required in E. coli to survive in environmental stresses such as that placed 
upon it by the ethanolic M. oleifera whole leaf extract treatment (Conrad et al., 1998; Karijolich, 
Yi, & Yu, 2015).  Enoyl-[acyl-carrier-protein] reductase [NADH] FabI was a protein enhanced by 
2-fold in E. coli according to proteomics data and is involved in fatty-acid biosynthesis, lipid 
metabolism, biotin biosynthesis, and has been associated with responses to antibiotics (Bergler 
et al., 1994; Chan & Vogel, 2010). The enhancement of this lipid synthesizing protein could be 
due to the bacterial cell trying to keep its membrane structure intact and membrane potential 
stable.  The periplasmic-binding functioning protein glutamate/aspartate periplasmic-binding 
protein was also enhanced 3-fold according to proteomics data (see Figure 16).  This 
periplasmic-binding functioning protein could be responsible for chemotaxis, transmembrane 
transport, and could play a role in dictating transcription based upon its evolutionary origin 
with a class of DNA-binding proteins (Aguilera et al., 2014; Tam & Saier Jr., 1993). 
Based on the already known activities of some of the identified clusters of bioactive 
compounds contained in the M. oleifera ethanol extracts, pterygospermin appears to inhibit the 
transaminase enzyme and causes membrane disruption in bacteria cells (Onyekaba, Omojate, & 
Anowi, 2013); Tannins, which are polyphenols, possess potent anti-bacterial proliferation 
activities exerted by blocking essential enzymes involved in microbial metabolism, such as the 
proteolytic macerating enzymes (Moyo, Masika, & Muchenje, 2012); Saponins induce 
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bacteriolysis by eliciting fatal structural changes in the cell membrane (Omojate, Enwa, Jewo, & 
Eze, 2014); Further, polyphenols, such as gallic acids likely act by binding to bacterial 
dihydrofolate reductase (DHFR) enzymes, subsequently inhibiting the supercoiling activity of 
E.coli bacterial gyrase via binding to the ATP binding site of gyrase B and to bacterial DNA, 
ultimately inducing topoisomerase IV enzyme-mediated DNA cleavage and bacterial growth 
stasis (Jayaraman, Sakharkar, Lim, Tang, & Sakharkar, 2010; Omojate et al., 2014). Ethanolic M. 
oleifera whole leaf extract appears to inhibit similar biological processes as the HPLC-isolated 
bioactive compounds in E.coli based on the analysis of current proteomics data. 
Although the exact reasons for this apparent advantage of Moringa over 
pharmaceuticals is for now unclear, it could be attributed to the presence of a cocktail of anti-
bacterial phytochemicals in the plant, which enables it to manipulate multiple biological 
processes of the bacterial synergistically. Indeed, in support of this speculation, our preliminary 
proteomics data shows that the plant alters expression of more than 64 proteins involved in 
various biological processes of E. coli, with 13 of the proteins being significantly changed. These 
biological processes are varied and include stress response, metabolism, translation, ribosomal 
synthesis, membrane synthesis, ATP synthesis, and other biological processes.  Future studies 
in our lab will verify these proteomics data and characterize the specific bioactive compounds 
inducing these biological changes and their underlying signaling pathways.  
For now, we do not know the specific target signature molecules (RNA/protein) that 
lead to the demise of the bacteria observed here as bacterial inhibition, delayed growth and 
structural changes. The mechanism of action by M. oleifera to cause these structural effects is 
probably multi-factorial through targeting many different cellular processes in the bacteria 
resulting in the structural changes reported in the present study, as revealed by the proteomics 
data. According to the data gathered, along with what has already been proposed previously we 
propose a working model which shows ethanolic M. oleifera inhibiting such processes as 
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ribosome synthesis, and translation; but increasing processes such as oxidative stress, 
membrane instability, DNA packaging, DNA fragmentation and DNA lysis in E. coli which will 
eventually culminate in lysis of the E. coli cell (see Figure 17).  Future studies should investigate 
trends in increased concentrations of extract on these processes.    
 Premature births are largely caused by bacterial infections, notably E. coli, one of the 
main causes implicated in infections associated with preterm labor. The growing resistance of 
bacteria to the current drugs of choice,  and the possible associated side effects of antibiotic use, 
demands an urgent development of safer but effective alternatives. We demonstrate here that 
pure ethanolic and hydro-ethanolic (80/20) M. oleifera extracts exert potent bactericidal 
properties against the bacteria E. coli that is greater than the other extracts and are  comparable 
to antibiotics of choice for this microbe. We also demonstrate the phases of growth of E. coli 
affected by the ethanolic M. oleifera whole leaf extract and compared these effects to common 
antibiotics.  These present data suggest a potential use of this medicinal plant in preventing E. 
coli-induced preterm labor, without the side effects associated with antibiotics. Going forward, 
there is need to conduct a more comprehensive study that will: a) identify the specific bioactive 
compounds inhibiting E. coli growth in whole leaf extract, b) compare the potency of whole leaf 
to the other parts of the plants, c) compare other solvents such as acetone, petroleum ether, 
ethyl acetate, and citrus terpenes; d) define the underlying mechanisms by which the extract 
inhibits bacterial growth; and e) test whether M. oleifera can inhibit preterm labor in animal 
models of preterm labor by blocking pathogenic bacterial strains. Ongoing studies in our lab are 
currently screening clusters of HPLC-isolated bioactive compounds, verifying proteomics data 
and delineating the underlying signaling pathways and mechanisms induced by whole leaf 
Moringa.  
 In summary, our data supports the current thinking in the field of medicinal plants, that 
Moringa oleifera whole-leaf ethanolic extract has antibacterial properties.  We also provide the 
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first expression profile for significantly changed proteins when E. coli is incubated with 
ethanolic M. oleifera extract and their pattern of expression to various biological processes 
revealed by proteomics.  From all the data gathered in the present study, we propose a working 
model for ethanolic M. oleifera whole leaf extract’s inhibition of E. coli.  Future studies will 
assess M. oleifera’s antibacterial properties against various other bacteria, including pathogenic 
E. coli strains, and whether the significantly changed proteins observed in the proteomics 
results are interconnected to specific compounds found in the ethanolic M. oleifera extract 
which results in lysis of the bacteria. 
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Tables 
Table 1: Different measurements used in preparing Moringa oleifera stock extracts.  
 
Label Amounts of Solution Total (µL) Concentration 
(mg/mL) 
H2O 290 μL Extract + 710 μL PBS 1000 1 
Ethanol/H2O 
(80/20) 
322 μL Extract + 678 μL PBS 1000 1 
Ethanol 357 μL Extract + 633 μL PBS 1000 1 
Methanol 48 μL Extract + 952 μL PBS 1000 1 
Butanol 625 μL Extract + 375 μL PBS 1000 1 
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Table 2: Parameters used for proteomics analysis in PEAKS program. 
 
Search Engine PEAKS 
Percent Mass Error 
Tolerance 
50.0 ppm 
Fragment Mass Error 
Tolerance 
0.5 Da 
Precursor Mass Search 
Type 
monoisotopic 
Enzyme Trypsin 
Max Missed Cleavages 3 
Non-specific Cleavage both 
Carbamidomethylation 
(C) 
57.02 
Oxidation (M) 15.99 
Formylation (Protein N-
term) 
27.99 
Max variable PTM per 
peptide 
3 
Database Uniprot_Sprot 
Taxon Escherichia 
coli 
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Table 3. Represents the minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) of five different M. oleifera extracts on E. coli growth 
(n=3).  
 
 
Extraction Solvent MIC (μg/mL) MBC (μg/mL) 
Ethanol 0.75 3 
Ethanol/Water (80/20) 1.5 7-8 
Butanol >20 >20 
Methanol >20 >20 
Water >20 >20 
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Table 4. Comparison of inhibition of E. coli by the antibiotic ciprofloxacin (5μg) to the ethanolic M. 
oleifera whole leaf extract at various concentrations. Ethanolic M. oleifera whole leaf extract 
(20μg) is able to produce the same inhibition zone as ciprofloxacin (5μg) against E. coli, but the 
extract at 25μg is able to inhibit 120% that of ciprofloxacin (5μg). 
Amount Substance(μg) Ciprofloxacin Inhibition 
(mm) 
Ethanolic Extract 
Inhibition (mm) 
Antibiotic vs. 
Extract (%) 
5 28 17 61 
10 - 21.5 77 
15 - 25.5 91 
20 - 28 100 
25 - 33.5 120 
 
  
  45 
 
Table 5. LD50 results for ethanolic M. oleifera extract and common antibiotics when 
treatment was able to reduce bacteria by half of the controls group absorbance.  Data 
shows that the Ethanolic M. oleifera extract requires the least amount of extract to inhibit 50% 
of E. coli growth (n=3). 
 
 LD50 (μg/mL) 
Ethanolic Moringa oleifera extract 2-2.5  
Tetracycline 7.5 
Streptomycin 4-5 
Ampicillin 12.5 
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Table 6. Proteins identified as significantly changed during proteomics analysis. 
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Figures 
 
Figure 1: Demonstrates streaking technique used to grow bacteria. 
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Figure 2. Measurement of the zone of Inhibitions: This Figure shows a diffusion assay of the 
M. oleifera ethanol extract at 10µg with the zone of inhibition and the 6 mm disk located in the 
center of the inhibition diameter. The tan area shows the E. coli, while the white area is the 
bacteria-free zone due to inhibition by ethanolic Moringa whole leaf extract and the black area 
is the 6 mm disk. 
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Figure 3. Diffusion assay showing inhibition zones of five M. oleifera extracts at 20 µg 
against E. coli: Data shows significant bacterial growth inhibition by M. oleifera pure ethanol 
extract and ethanol/water (80/20) extract. Water, butanol and methanol extracts did not 
inhibit E. coli growth. Diameter of the discs used were 6mm and an inhibition of 6mm indicates 
no inhibition by the extract. * p ≤0.05 Eth/water vs. water; ** p ≤0.05 Ethanol vs. Eth/water; *** 
p≤0.05 Ethanol vs. water (n=3).  
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Figure 4.  Diffusion assay showing diameter of the inhibition zone of M. oleifera pure 
ethanolic and hydro-ethanolic M. oleifera extracts at increasing amounts against E. coli: 
Data shows dose-dependent inhibition of bacterial growth by Diffusion assay for M. oleifera 
pure ethanolic and hydro-ethanolic Moringa extracts. The pure ethanolic extract displayed a 
more potent inhibitory effect on E. coli growth compared to the hydro-ethanolic extract. 
Diameter of the discs used were 6mm and an inhibition zone of 6mm indicates no inhibition by 
the extract.     * p ≤0.05, 1 vs. 5 μg; ** p ≤0.05, 1 vs. 10 μg; *** p ≤0.05, 1 vs. 15 μg; **** p ≤0.05, 1 
vs. 20 μg (n=3).  
  
  51 
 
 
 
Figure 5. Comparisons of inhibition zones of M. oleifera pure and hydroethanolic M. 
oleifera extracts versus antibiotics (Tetracycline, ciprofloxacin, and clindamycin) at similar 
amounts (5 μg) against E. coli: The zone of inhibition of both M. oleifera ethanolic and hydro-
ethanolic extracts were approximately two-thirds the size of ciprofloxacin but significantly 
larger than both tetracycline and clindamycin. Diameter of the discs used were 6mm and an 
inhibition zone of 6mm indicates no inhibition by the extract. *p≤0.01, Clindamycin vs. 
Ciprofloxacin;  p ≤0.01, Tetracycline vs. Ciprofloxacine; *** p ≤0.05, Eth/Water vs. 
Ciprofloxacine; **** p ≤ 0.05, Ethanol vs. Ciprofloxacine (n=3).   
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Figures 6. Diffusion assay showing the respective amounts at which ciprofloxacin (5 µg) 
and pure ethanol M. oleifera extracts (25 µg) attain comparable diameter inhibition zones 
against E. coli: M. oleifera pure ethanolic whole leaf extract at 20/25 μg attains a greater 
diameter of zone of (E. coli growth) inhibition to ciprofloxacin at 5 μg.  Diameter of the discs 
used were 6mm and an inhibition zone of 6mm indicates no inhibition by the extract. *p≤0.05, 
Ethanol (25µg) vs. Ciprofloxacin (5µg). 
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Figure 7. Antibacterial kinetic plots of M. oleifera ethanol extract against 1500 CFU of E. 
coli cells: M. oleifera treatments show a longer lag phase and reduced growth for 3 μg treatment 
compared to positive control. M. oleifera treatment of 6 μg inhibited all growth of E. coli. * p 
≤0.05, 3.0 μg/mL vs. Pos. C at 16h; ** p ≤ 0.05, 3.0 μg/mL vs. Pos. C. and 3.0 μg/mL vs. 0.75 
μg/mL and 3.0 μg/mL vs. 1.5 μg/mL at 24h; *** p ≤ 0.05, 3.0 μg/mL vs. Pos. C. and 3.0 μg/mL vs. 
0.75 μg/mL and 3.0 μg/mL vs. 1.5 μg/mL at 48h; **** p ≤ 0.05, 3.0 μg/mL vs. Pos. C. and 3.0 
μg/mL vs. 0.75 μg/mL and 3.0 μg/mL vs. 1.5 μg/mL at 72h (n=3). 
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Figure 8. Antibacterial kinetic plots of the antibiotic ampicillin against 1500 CFU of E. coli 
cells:  Ampicillin treatments showed significant inhibition of E. coli cells at ½ LD50, LD50 and 
2x LD50 at the 8h time point. The 2x LD50 ampicillin treatment showed significant inhibition of 
growth of E. coli cells at the 16h time point. *p ≤ 0.05, Pos. C vs. ½ LD50 and Pos. C vs. LD50 and 
Pos. C vs. 2x LD50 at 8h; **p ≤ 0.05, Pos. C vs. 2x LD50 at 16h (n=3). 
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Figure 9. Antibacterial kinetic plots of the antibiotic streptomycin against 1500 CFU of E. 
coli cells:  Streptomycin treatments show a longer lag phase and reduced growth at  2xLD50 
compared to the positive control. *p ≤ 0.05, Pos. C vs. LD50 and Pos. C vs. ½ LD50 and Pos. C vs. 
2xLD50 at 8h; **p ≤ 0.05, Pos. C vs. ½ LD50 and Pos. C vs. LD50 and Pos. C vs. 2xLD50 at 16h; 
***p ≤ 0.05, Pos. C vs. ½ LD50 and Pos. C vs. LD50 and Pos. C vs. 2xLD50 at 24h; ****p ≤ 0.05, 
Pos. C vs. 2xLD50 at 48h; *****p ≤ 0.05, Pos. C vs. 2xLD50 at 72h (n=3). 
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Figure 10. Antibacterial kinetic plots of the antibiotic tetracycline against 1500 CFU of E. 
coli cells:  Tetracycline treatments showed a longer lag phase and reduced growth at treatment 
concentrations of LD50 and 2x LD50 compared to the positive control. At a tetracycline 
treatment concentration of ½ LD50 a notable difference was observed at 8h, and 16h when 
compared to the positive control. *p ≤ 0.05, Pos. C vs. ½ LD50 and Pos. C vs. LD50 and Pos. C vs. 
2x LD50 at 8h; **p ≤ 0.05, Pos. C vs. ½ LD50 and Pos. C vs. LD50 and Pos. C vs. 2x LD50 at 16h; 
***p ≤ 0.05, Pos. C vs. LD50 and Pos. C vs. 2x LD50 at 24h; ****p ≤ 0.05, Pos. C vs. LD50 and Pos. 
C vs. 2x LD50 at 48h; *****p≤ 0.05, Pos. C vs. LD50 and Pos. C vs. 2x LD50 at 72h (n=3). 
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Figure 11. Quantitative proteomics analysis of protein expression in E. coli treated with 
ethanolic whole leaf M. oleifera extract (2.5μg/mL).  Approximately 64 proteins were 
identified, with a small subset demonstrating statistically significant changes in E. coli treated 
with M. oleifera.  Red indicates higher protein expression compared to baseline control, and 
green indicates lower protein expression compared to baseline control. Control treatments (C1, 
C3), M. oleifera treatments (M3, M5).  
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Figure 12. M. oleifera modulates a plethora of key biological processes and protein 
expression in E. coli, such as ATP and protein synthesis, as well as factors involved in 
metabolism, stress response and membrane function, as revealed by proteomics analysis: 
Biological processes that are altered by protein expression when E. coli’s treated with ethanolic 
M. oleifera whole leaf extract. Almost two thirds of the proteins are involved in metabolism and 
stress response.  Of the 64 proteins changed during the ethanolic M. oleifera treatment, only 13 
were significantly changed. 
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Figure 13.  Specific stress response proteins in E. coli altered by ethanolic extract of M. 
oleifera, as revealed by proteomics analysis.  Four stress response proteins, namely isocitrate 
dehydrogenase (IDH), DNA-binding protein HU-alpha, ornithine carbamoyltransferase chain F 
and alcohol dehydrogenase propanol-preferring (ADHP) were variably expressed in E. coli 
treated with M. oleifera compared to the control group. Overall, these proteins were all 
significantly up regulated, except for DNA-binding protein HU-alpha, which was down 
regulated. *p ≤ 0.05 (n=3). 
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Figure 14. Specific metabolic proteins in E. coli altered by ethanolic extract of M. oleifera, as 
revealed by proteomics analysis.  Two metabolic proteins, namely Oxidoreductase YajO, and 
malate dehydrogenase (MDH) were variably expressed in E. coli treated with M. oleifera 
compared to the control group. These proteins were significantly up regulated. *p≤ 0.05 (n=3). 
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Figure 15. Specific ATP synthesizing proteins in E. coli altered by ethanolic extract of M. 
oleifera, as revealed by proteomics analysis.  Three ATP synthesizing proteins, namely ATP 
synthase subunit C, Succinyl-CoA ligase subunit beta (SUCC), and Succinyl-CoA ligase subunit 
alpha (SUCD) were variably expressed in E. coli treated with M. oleifera compared to the control 
group. These proteins were all significantly up regulated. *p ≤ 0.05 (n=3). 
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Figure 16. A variety of proteins involved in various biological processes in E. coli altered by 
ethanolic extract of M. oleifera, including translation, ribosome synthesis, membrane 
synthesis and periplasmic-binding, as revealed by proteomics analysis.  Various proteins 
involved in a cross section of biological functions in E. coli, including translation (50S ribosomal 
protein L5), ribosomal function (ribosomal large subunit pseudouridine synthase B), membrane 
function (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI), and unknown 
(glutamate/aspartate periplasmic-binding protein, were variably expressed in E. coli treated 
with M. oleifera compared to the control group. Overall, all the proteins were significantly up 
regulated, except for 50S ribosomal protein 1.5, which was down regulated. *p ≤ 0.05 (n=3). 
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Figure 17. Proposed mechanism of action of Moringa oleifera on Escherichia coli. Several 
different biological processes in E. coli likely to be under influence by ethanolic M. oleifera 
whole leaf extract treatment which leads to lysis of the bacterial cell. The pathways that are 
blocked in E. coli by the ethanolic M. oleifera whole leaf extract treatment include Ribosome 
production, and Translation. The pathways that are enhanced by the ethanolic M. oleifera whole 
leaf extract treatment in E. coli include Metabolism, DNA packaging, DNA fragmentation, 
Membrane Instability, Oxidative stress, and Cell lysis. 
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